We are live on
!
Find out more
Lineage Cell Therapeutics
LCTX
LCTX
130 hedge funds and large institutions have $176M invested in Lineage Cell Therapeutics in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
495% more call options, than puts
Call options by funds: $226K | Put options by funds: $38K
100% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 12
42% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 26
6% more funds holding
Funds holding: 123 → 130 (+7)
4% more capital invested
Capital invested by funds: $170M → $176M (+$6.71M)
0.7% more ownership
Funds ownership: 44.14% → 44.84% (+0.7%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
130
Holders Change
+7
Holders Change %
+5.69%
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.02%
New
24
Increased
37
Reduced
26
Closed
12
Calls
$226K
Puts
$38K
Net Calls
+$188K
Net Calls Change
+$123K
Top Buyers
| 1 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$7.76M |
| 2 |
Millennium Management
New York
|
+$5.82M |
| 3 |
AC
Armistice Capital
New York
|
+$5.37M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$2.87M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$634K |
| 2 |
Renaissance Technologies
New York
|
-$472K |
| 3 |
Goldman Sachs
New York
|
-$454K |
| 4 |
Two Sigma Investments
New York
|
-$298K |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$294K |
